Hasan Burak Isleyen MD, FACVC

Research and open science

From clinical questions to reproducible evidence.

The programme connects cardio-oncology, critical-care cardiology, pharmacovigilance, real-world evidence, echocardiography, clinical AI, and machine learning.

Research programme

Six connected themes

01

Cardio-oncology

Cardiovascular events associated with cancer therapies, critical-care outcomes, and treatment safety.

02

Acute and critical-care cardiology

Heart failure, acute myocardial infarction, arrhythmias, and longitudinal clinical outcomes.

03

Real-world evidence and pharmacovigilance

Clinical-outcome and safety research using large data resources including MIMIC-IV, eICU, and FAERS.

04

Clinical AI and machine learning

Explainable models, temporal validation, calibration, decision-curve analysis, and clinical utility.

05

Echocardiography and cardiac phenotyping

Ventricular volumes, valvular disease, filling pressure, and measurement discordance in relation to outcomes.

06

Interventional cardiology

Coronary intervention, no-reflow, procedural outcomes, and the domestic medical-device ecosystem.

Current projects

Projects in development or review

Principal investigator

CardioOnco-SAFE

An AI-supported clinical decision-support prototype for cardiovascular adverse events associated with cancer therapies.

The TRY 12,000,000 project proposal received preliminary approval under the TUSEB C4 programme; final scientific review and the funding decision remain pending.

Applicant and inventor

CardioMetric

A portable transparent educational device supporting ECG evaluation and basic measurement steps.

Patent application 2026/000366 is under examination.

The CardioOnco-SAFE budget refers to the submitted proposal. Funding has not been awarded. No financial conflict of interest is declared.